Latest News and Press Releases
Want to stay updated on the latest news?
-
Kaplan Fox notifies investors of Class Action filed against Eagle Pharmaceuticals.
-
Kaplan Fox & Kilsheimer LLP reminds investors that a complaint has been filed on behalf of purchasers of the common stock of Veradigm Inc.
-
Kaplan Fox & Kilsheimer LLP reminds investors that a complaint has been filed on behalf of investors who purchased or otherwise acquired LivePerson, Inc.
-
Kaplan Fox & Kilsheimer LLP reminds investors that a complaint has been filed on behalf of purchasers of the common stock of Veradigm Inc.
-
Kaplan Fox reminds investors that a complaint has been filed on behalf of investors that purchased or otherwise acquired ChargePoint Holdings, Inc.
-
Kaplan Fox & Kilsheimer LLP is investigating potential claims on behalf of investors who purchased securities of Eagle Pharmaceuticals, Inc.
-
Kaplan Fox & Kilsheimer LLP is investigating potential claims on behalf of investors who purchased Acelyrin, Inc.
-
NEW YORK, Dec. 05, 2023 (GLOBE NEWSWIRE) -- Kaplan Fox & Kilsheimer LLP reminds investors that a complaint has been filed on behalf of purchasers of the common stock of Veradigm Inc. (“Veradigm”...
-
NEW YORK, Dec. 05, 2023 (GLOBE NEWSWIRE) -- Kaplan Fox & Kilsheimer LLP reminds investors that a complaint has been filed on behalf of investors that purchased or otherwise acquired the...
-
Kaplan Fox is investigating potential claims on behalf of investors who purchased securities of Woodcliff Lake, New Jersey-based Eagle Pharmaceuticals, Inc